CRUISE System for Emergency Shock Treatment
Part of Injuries & trauma clinical trials.
This trial tests a CRUISE system to help treat patients in shock (a life-threatening condition where the body isn't getting enough blood flow) in emergency settings. It aims to see if this system can improve care when used by emergency medical services or in hospitals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You cannot have active atrial fibrillation (irregular heartbeat) or other irregular heart rhythms
- You cannot have an open chest wound or recent open-chest surgery
- You cannot have known right ventricular failure (a specific type of heart weakness)
- You must be evaluated or treated by UPMC Emergency Medical Services or arrive at a UPMC hospital where the study team can access your medical records
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether digital out-of-hospital management improves outcomes for patients who have recovered from early-stage cardiogenic shock. If you have been discharged after treatment for this condition and can use a smartphone, you may be eligible.
This trial is testing a new system called Argos to see if it can measure how much blood your heart pumps more easily than current methods. It is for patients already in the ICU who need a quick change in fluids or blood pressure medicine.
This trial tests a new device that measures heart function closely after heart surgery. It may help doctors give better care if you are in the heart intensive care unit after your operation.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial tests a team-based care approach for people having a severe heart attack that leads to cardiogenic shock (when the heart can't pump enough blood). The goal is to see if a coordinated team of specialists can improve survival and recovery.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.